GlassScriptPhysician profile
Ketan B Patel
NPI 1447254131
$13,701.85
in general payments reported to CMS, 2019-2025
31 companies · $509 in 2025
The $509 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $166 · 2021: $132 · 2022: $4,197 · 2023: $4,483 · 2024: $3,805 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $6,493 · Food and Beverage: $2,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $6,492.72 |
| Food and Beverage | $2,304.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $10,027.08 | 2022-2025 | Orbitum Staple System |
| Kerecis Limited | $923.47 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Horizon Therapeutics Plc | $379.75 | 2019-2023 | Krystexxa |
| Bioventus LLC | $349.14 | 2023-2025 | Exogen Ultrasound Bone Healing System, Durolane, Xcell |
| Flower Orthopedics Coporation | $272.88 | 2022 | |
| Amgen INC. | $189.94 | 2024-2025 | Krystexxa |
| Medtronic, INC. | $183.87 | 2022-2024 | Closurefast, Venaseal, Intellis Adaptivestim |
| Nevro Corp. | $158.90 | 2022 | |
| Medline Industries LP | $149.44 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $134.98 | 2019 | |
| Trice Medical, INC. | $117.11 | 2023 | |
| Intravu INC. | $108.96 | 2019 | |
| Djo, LLC | $103.04 | 2024 | Dr Comfort |
| Trilliant Surgical LLC. | $77.59 | 2019 | |
| Medshape, INC. | $69.17 | 2024 | Dynanail Helix, Washer, 15 Mm |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $57.46 | 2025 | |
| Ani Pharmaceuticals, INC. | $57.04 | 2025 | Purified Cortrophin Gel |
| Smith+Nephew, INC. | $56.31 | 2021-2023 | Grafix |
| Dynasplint Systems INC. | $43.70 | 2021 | |
| Atland Pharmaceuticals, LLC | $27.05 | 2025 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
| Triad Life Sciences INC. | $26.21 | 2022 | |
| Lifenet Health | $24.32 | 2024 | Theragenesis Wound Matrix |
| Ets Wound Care LLC | $22.10 | 2025 | Mirragen Advanced Wound Matrix |
| Zimmer Biomet Holdings, INC. | $21.54 | 2021 | |
| Averitas Pharma INC. | $21.03 | 2024 | Qutenza |
| Mimedx Group, INC. | $19.96 | 2025 | |
| Heron Therapeutics, INC. | $19.51 | 2021 | |
| Nabriva Therapeutics, Plc | $18.11 | 2022 | |
| Axogen | $17.95 | 2019 | |
| Stimwave Technologies Incorporated | $14.33 | 2021 | |
| Reprise Biomedical, INC. | $9.91 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ketan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.